EntitiesEQT Life Sciences

Investor Dossier

EQT Life Sciences

active
Typeinvestor
Location

Portfolio (2 investments)

ImCheck Therapeutics

Series C · Jun 2022

€96.0M

Amolyt Pharma

Series C · Jan 2023

€128.1M

Links